CYP‐mediated drug–drug interactions with evacetrapib, an investigational CETP inhibitor: in vitro prediction and clinical outcome-Reference-Cited by-同舟云学术

CYP‐mediated drug–drug interactions with evacetrapib, an investigational CETP inhibitor: in vitro prediction and clinical outcome

Published:2015-10-27 Issue:6 Volume:80 Page:1388-1398
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Cannady Ellen A.¹,Suico Jeffrey G.¹²,Wang Ming‐Dauh¹,Friedrich Stuart¹,Rehmel Jessica R. F.¹,Nicholls Stephen J.³²,Krueger Kathryn A.¹

Affiliation:

1. Eli Lilly and Company, Departments of Clinical Pharmacology, Drug Disposition, Medical, and Statistics, Lilly Research Laboratories Eli Lilly and Company Indianapolis Indiana

2. Principal Investigator Eli Lilly and Company Indianapolis Indiana USA

3. South Australian Health & Medical Research Institute University of Adelaide Adelaide Australia

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.12730

Reference21 articles.

1. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

2. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

3. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

4. Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes

5. Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the potential drug–drug interactions of carotegrast methyl with midazolam, prednisolone or atorvastatin in healthy adults;British Journal of Clinical Pharmacology;2023-12-19

2. An updated review of pharmacokinetic drug interactions and pharmacogenetics of statins;Expert Opinion on Drug Metabolism & Toxicology;2020-08-06

3. Current trends in drug metabolism and pharmacokinetics;Acta Pharmaceutica Sinica B;2019-11

4. Statins: Adverse reactions, oxidative stress and metabolic interactions;Pharmacology & Therapeutics;2019-03

5. Ilexgenin A enhances the effects of simvastatin on non-alcoholic fatty liver disease without changes in simvastatin pharmacokinetics;Chinese Journal of Natural Medicines;2018-06